US Stock MarketDetailed Quotes

Beam Therapeutics (BEAM)

Watchlist
  • 28.140
  • +0.370+1.33%
Close Dec 24 13:00 ET
  • 28.190
  • +0.050+0.18%
Post 15:15 ET
2.86BMarket Cap-6.14P/E (TTM)

Beam Therapeutics (BEAM) Key Financial Indicators

BEAM Earnings per Share (EPS)

According to the latest financial report of Beam Therapeutics, the latest earnings per share (TTM) for the company is -1.10. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

BEAM Free Cash Flow (FCF)

Interested in knowing about Beam Therapeutics's free cash flow? The latest report shows it as -86.49M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

BEAM Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Beam Therapeutics shows that the company's current ratio is 6.02, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

BEAM Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Beam Therapeutics, the quick ratio is 5.89, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

BEAM Return on Equity (ROE)

Want to learn more about the financial health of Beam Therapeutics? The latest ROE figure is -11.20%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

BEAM Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Beam Therapeutics, the total asset return on investment (ROA) is -8.34%.

Currency: USD

Quarterly

Loading...

BEAM Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Beam Therapeutics's latest financial report to see how their gross margin is doing - currently at --.

Currency: USD

Quarterly

Loading...

BEAM Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Beam Therapeutics, the net profit margin is -1.16K%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More